EUVIMEDScopri EUVIMED
Open access

Berberine Improved the Therapeutic Efficacy of UC ‐ MSCs for DSS ‐Induced Colitis via Aerobic Glycolysis

Mengye Wu, Cuiping Li, Jianqi Feng, Xiaolu Guo, Rui Fang, Qinghai Lian, Xiaoran Zhang, Jianping Ma, Yanling Li, Shujuan Xie, Haiyan Zhang, Yanwen Peng iD

Phytotherapy Research · 2026-08 · 40 (8) · 5193-5207

DOI: 10.1002/ptr.70372 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-05-24. Written by Mengye Wu and 11 co-authors. Institution: The Biotherapy Center, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. Major MEDLINE topics: Berberine, Glycolysis, Mesenchymal Stem Cells, Colitis. Cited 1 times so far (Crossref); 58 references. The full text is freely available in PubMed Central. Funded by: Shenzhen Nanshan District Science and Technology Program, Sanming Project of Medicine in Shenzhen Nanshan, The National Natural Science Foundation of China.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The global prevalence of inflammatory bowel disease (IBD) continues increasing, but effective targeted treatments remain elusive. Recently, mesenchymal stem cells (MSCs) have emerged as a promising candidate for IBD treatment, with energy metabolism playing a critical role. Berberine (BBR), a natural extract from Berberidaceae plants, has been shown to modulate various cell functions by reprogramming metabolism in immune‐related diseases. This study aims to investigate the influence of BBR on the therapeutic effectiveness of MSCs in colitis. Using the colitis mice model, we compared the therapeutic effects of BBR treated MSCs (MSC BBR ) and untreated MSCs by evaluating colon length, Disease Activity Index, and histopathological change. Various methods were employed to detect the differences of MSC BBR and MSCs, including seahorse analysis for energy metabolism, RNA‐seq and qPCR for gene transcription, western blotting for protein expression, flow cytometry for phenotypic analysis, and cytokine production. Our results revealed that BBR treatment activated the AMPK signaling pathway, upregulated the expression of glucose transporter 1 (GLUT1), and promoted aerobic glycolysis in MSCs. Comparing to MSCs, MSC BBR exhibited the increased expression of tumor necrosis factor‐stimulated gene‐6 (TSG‐6), enhanced immunomodulatory function and superior therapeutic efficacy. Inhibition of either glycolysis or TSG‐6 expression impaired the therapeutic effect of MSC BBR , while overexpression of GLUT1 or TSG‐6 obviously improved the therapeutic efficacy of MSCs. BBR treatment improved the therapeutic effect of MSCs in colitis by promoting aerobic glycolysis, providing a safe new approach for optimizing MSCs‐based therapy in IBD through reprogramming energy metabolism.

Subjects

MeSH terms (MEDLINE)

BerberineGlycolysisMesenchymal Stem CellsColitisMesenchymal Stem Cell TransplantationAnimalsMiceDextran SulfateMaleDisease Models, AnimalMice, Inbred C57BLSignal TransductionGlucose Transporter Type 1

Author keywords

AMPK pathwayberberine (BBR)glucose transporter 1 (GLUT1)glycolysisinflammatory bowel disease (IBD)mesenchymal stem cells (MSCs)

Substances

BerberineDextran SulfateGlucose Transporter Type 1

Authors and institutions

  • The Biotherapy Center, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Center for Stem Cells Translational Medicine, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangdong, China.
  • Cell-Gene Therapy Translational Medicine Research Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

ORCID profiles: Yanwen Peng

Funding

  • Shenzhen Nanshan District Science and Technology Program
  • Sanming Project of Medicine in Shenzhen Nanshan
  • The National Natural Science Foundation of China
  • Fundamental and Applied Basic Research of Guangzhou City University (Institution) Projects
  • Natural Science Foundation of Guangdong Province
  • Key Research and Development Program of Guangdong Province
  • Guangzhou Science and Technology Plan Projects
  • Special Project for Research and Development in Key areas of Guangdong Province

Cite

APA

Wu, M., Li, C., Feng, J., Guo, X., Fang, R., Lian, Q., Zhang, X., Ma, J., Li, Y., Xie, S., Zhang, H., & Peng, Y. (2026). Berberine Improved the Therapeutic Efficacy of UC ‐ MSCs for DSS ‐Induced Colitis via Aerobic Glycolysis. Phytotherapy Research, 40(8), 5193-5207. https://doi.org/10.1002/ptr.70372

Vancouver

Wu M, Li C, Feng J, Guo X, Fang R, Lian Q, et al. Berberine Improved the Therapeutic Efficacy of UC ‐ MSCs for DSS ‐Induced Colitis via Aerobic Glycolysis. Phytotherapy Research. 2026;40(8):5193-5207. doi:10.1002/ptr.70372

BibTeX
@article{Wu2026,
  author = {Wu, Mengye and Li, Cuiping and Feng, Jianqi and Guo, Xiaolu and Fang, Rui and Lian, Qinghai and Zhang, Xiaoran and Ma, Jianping and Li, Yanling and Xie, Shujuan and Zhang, Haiyan and Peng, Yanwen},
  title = {Berberine Improved the Therapeutic Efficacy of UC ‐ MSCs for DSS ‐Induced Colitis via Aerobic Glycolysis},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {8},
  pages = {5193--5207},
  doi = {10.1002/ptr.70372}
}
Start for free →